Research from e27, e27

Research from e27

e27 is Asia's largest Tech media platform. We cover the latest news on emerging and disruptive businesses across the region.

Private Capital Markets

Automera Pte Ltd / Private Capital Markets

<ul><li>Singapore-based biotechnology startup Automera has secured US$16 million in a Series A round of investment co-led by early-stage life science accelerator and investment firm Accelerator Life Science Partners (ALSP) and Temasek-backed venture builder ClavystBio.</li><li>EDBI, Xora Innovation, and other undisclosed investors also participated.</li><li>Automera was established by Associate Professor Michael Lazarou, Loong Wang, and Taiyang Zhang at Talo Labs in collaboration with ALSP.</li></ul>

Singapore-based biotechnology startup Automera has secured US$16 million in a Series A round of investment co-led by early-stage life science accelerator and investment firm Accelerator Life Science Partners (ALSP) and Temasek-backed venture builder ClavystBio.EDBI, Xora Innovation, and other undisclosed investors also participated.Automera was established by Associate Professor Michael Lazarou, Loong Wang, and Taiyang Zhang at Talo Labs in collaboration with ALSP.

Singaporean Biotech Startup Automera Secures US$16M Series A Financing

Singapore

Automera Pte. Ltd. operates as a biotechnology company. The Company focuses on the development of a novel therapeutic approach via autophagy-based targeted protein degradation. Automera serves customers in the United States and Singapore.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Automera Pte Ltd (2308524D SP)

Singaporean Biotech Startup Automera Secures US$16M Series A Financing

Singapore-based biotechnology startup Automera has secured US$16 million in a Series A round of investment co-led by early-stage life science...

e27

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)